Understanding the causes of PACS1 Syndrome and its effects on brain development
Identifying pathogenic mechanisms underlying PACS1 Syndrome: implications for neural development - Research Supplement to PromoteDiversity in Health-Related Research #2
This study is looking into PACS1 Syndrome, a condition that affects how the brain develops and works, to better understand the genetic changes behind it and find new ways to help those who have it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11090151 on NIH RePORTER |
What this research studies
This research investigates PACS1 Syndrome, a neurodevelopmental disorder that affects cognitive function and is linked to a specific genetic mutation. The study aims to uncover the molecular and cellular mechanisms disrupted by this mutation, which could lead to better understanding and potential treatments for affected individuals. By examining how the PACS1 protein functions in the brain, researchers hope to identify new therapeutic targets that could improve outcomes for patients. The research involves advanced genetic and cellular techniques to analyze the effects of the PACS1 mutation on brain development.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with PACS1 Syndrome or related neurodevelopmental disorders.
Not a fit: Patients with neurodevelopmental disorders not related to PACS1 Syndrome may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of targeted therapies that improve cognitive function and quality of life for individuals with PACS1 Syndrome.
How similar studies have performed: Previous research has shown promise in understanding genetic contributions to neurodevelopmental disorders, suggesting that this approach could yield valuable insights.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Guemez Gamboa, Alicia Dione — Northwestern University at Chicago
- Study coordinator: Guemez Gamboa, Alicia Dione
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.